A Ligand for CD5 Is CD5

被引:51
|
作者
Brown, Marion H. [1 ]
Lacey, Erica [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 185卷 / 10期
基金
英国医学研究理事会;
关键词
CYSTEINE-RICH DOMAIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL SURFACE-IMMUNOGLOBULIN; POTENTIAL SELECTING LIGAND; RAT T-LYMPHOCYTES; SCAVENGER RECEPTOR; SRCR DOMAIN; MONOCLONAL-ANTIBODY; NATURAL-KILLER; B-CELLS;
D O I
10.4049/jimmunol.0903823
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recognition by scavenger receptor cysteine-rich domains on membrane proteins regulates innate and adaptive immune responses. Two receptors expressed primarily on T cells, CD5 and CD6, are linked genetically and are structurally similar, both containing three scavenger receptor cysteine-rich domains in their extracellular regions. A specific cell surface interaction for CD5 has been difficult to define at the molecular level because of the susceptibility of CD5 protein to denaturation. By using soluble CD5 purified at neutral pH to preserve biological activity, we show that CD5 mediates species-specific homophilic interactions. CD5 domain 1 only is involved in the interaction. CD5 mAbs that have functional effects in humans, rats, and mice block homophilic binding. Ag-specific responses by mouse T cells in vitro were increased when engagement of human CD5 domain 1 was inhibited by mutation or by IgG or Fab fragment from a CD5 mAb. This showed that homophilic binding results in productive engagement. Enhancement of polyclonal immune responses of rat lymph node cells by a Fab fragment from a CD5 mAb shown to block homophilic interactions provided evidence that the extracellular region of CD5 regulates inhibition in normal cells. These biochemical and in vitro functional assays provide evidence that the extracellular region of CD5 regulates immunity through species-specific homophilic interactions. The Journal of Immunology, 2010, 185: 6068-6074.
引用
收藏
页码:6068 / 6074
页数:7
相关论文
共 50 条
  • [21] VH gene expression in CD5 positive and CD5 negative B cell chronic lymphoid malignancies
    Maloum, K
    Pritsch, O
    Magnac, C
    Davi, F
    Binet, JL
    MerleBeral, H
    Dighiero, G
    LEUKEMIA & LYMPHOMA, 1997, 24 (5-6) : 437 - 448
  • [22] Characterization of porcine CD5 and CD5+ B cells
    Appleyard, GD
    Wilkie, BN
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (01): : 225 - 230
  • [23] T-cells resist CD5 CAR mediated fratricide by continuously degrading CD5 protein
    Ma, Royce
    Popat, Divya
    Chaumette, Alex
    Carisey, Alexandre
    Brenner, Malcolm K.
    Mamonkin, Maksim
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [24] CD5 CAR T-Cells Avoid Self-Elimination by Continuously Degrading CD5 Protein
    Ma, Royce
    Popat, Divya
    Chaumette, Alex
    Carisey, Alexandre
    McKenna, Mary K.
    Srinivasan, Madhuwanti
    Watanabe, Norihiro
    Brenner, Malcolm K.
    Mamonkin, Maksim
    MOLECULAR THERAPY, 2021, 29 (04) : 36 - 36
  • [25] Transcriptional regulation of human CD5:: Important role of Ets transcription factors in CD5 expression in T cells
    Arman, M
    Calvo, J
    Trojanowska, ME
    Cockerill, PN
    Santana, M
    López-Cabrera, M
    Vives, J
    Lozano, F
    JOURNAL OF IMMUNOLOGY, 2004, 172 (12): : 7519 - 7529
  • [26] CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells
    Carmo, AM
    Castro, MAA
    Arosa, FA
    JOURNAL OF IMMUNOLOGY, 1999, 163 (08): : 4238 - 4245
  • [27] CD5 PID further characterization.
    Weller, S
    Doeffinger, R
    Wasserbauer, N
    Wells, JC
    Ochs, H
    Cassanova, J
    Hostoffer, R
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S130 - S131
  • [28] Fine tuning of TCR signaling by CD5
    Azzam, HS
    DeJarnette, JB
    Huang, K
    Emmons, R
    Park, CS
    Sommers, CL
    El-Khoury, D
    Shores, EW
    Love, PE
    JOURNAL OF IMMUNOLOGY, 2001, 166 (09): : 5464 - 5472
  • [29] CD5 B-CELLS IN THE RAT
    DEBOER, NK
    AMMERLAAN, WAM
    MEEDENDORP, B
    KROESE, FGM
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 157 - 159
  • [30] CD5, an Undercover Regulator of TCR Signaling
    Voisinne, Guillaume
    de Peredo, Anne Gonzalez
    Roncagalli, Romain
    FRONTIERS IN IMMUNOLOGY, 2018, 9